Scientific Library
Article
Reprogramming stem cells: a new innovative technology for the development of consistent and functional human cells
November 26, 2020
To overcome current cell model limitations, bit.bio have developed a new, innovative technology to reprogram human stem cells with precise control of transcription factor expression through iPSC engineering.
Article
Consistent, scalable human iPSC-derived glutamatergic neurons and skeletal myocytes
November 26, 2020
As detailed in a separate post, bit.bio have developed a novel cellular reprogramming technology, opti-ox™1 (optimized inducible overexpression), that can generate functional cells with high consistency
Article
Powering Immuno-Oncology Research: Tebubio’s Selected iXCells Biotechnologies Immune Cell Range
April 16, 2025
Boost the reliability of your Immuno-Oncology research with Tebubio’s expert selection of iXCells immune cells.
From fresh PBMCs to CD4+, CD8+, NK cells and beyond—this resource highlights the best tools